Fingerprint
Dive into the research topics of 'Growth of pancreatic cancers with hemizygous chromosomal 17p loss of MYBBP1A can be preferentially targeted by PARP inhibitors'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Growth of pancreatic cancers with hemizygous chromosomal 17p loss of MYBBP1A can be preferentially targeted by PARP inhibitors
Antony Hsieh, Jason R. Pitarresi, Jonathan Lerner, Greg Donahue, David Hsiehchen, Anil K. Rustgi, Kenneth Zaret
Research output: Contribution to journal › Article › peer-review
3
Scopus
citations